Notably, patient 21 had no family history of cancer but was found to harbor a pathogenic mutation in RECQL4, which has been implicated in type II Rothmund–Thomson syndrome characterized by a premature aging phenotype [47]. This evidence concerns the gene RECQL4 and cancer.